Pharma Reviews: IPC awarded Observer Status for EDQM, to organize drug standards & regulatory update ...

The Indian Pharmacopoeia Commission (IPC), an autonomous institute under the Ministry of Health and Family Welfare, mandated for drug standard setting ... The symposium shall be the unique opportunity for the stakeholders, which may include professionals from Pharma Industry, API Manufacturers, ...
Read more: IPC awarded Observer Status for EDQM, to organize drug standards & regulatory update ...

Pharma Reviews: In a 5 or 10-year horizon, I am as bullish as ever: Rakesh Jhunjhunwala

I am quite sure that if I see an angle of 5 to 10 years, regardless of what happens in the international market, the Indian markets are going to perform well. May be if the ... Now Indian pharma companies had two challenges – one FDA problems that is more like a manufacturing problem, second is pricing.
Read more: In a 5 or 10-year horizon, I am as bullish as ever: Rakesh Jhunjhunwala

Pharma Reviews: Can pharma learn from auto? Of course!

The drug industry, traditionally growing via medical breakthroughs, is facing threats from unexpected rivals such as Google and Samsung, while the auto sector is grappling with new-age nemeses like Google and Tesla. At the India Pharmaceutical Forum, a gathering of top manufacturing quality ...
Read more: Can pharma learn from auto? Of course!

Pharma Reviews: Indian pharma cos bracing up to comply with European General Data Protection Regulation

With new European General Data Protection Regulation (GDPR) slated to be enforced from May 25, 2018 to strengthen data protection for all European origin individuals and businesses, the Indian pharmaceutical industry with operations in EU or having distribution partners, CROs, software vendors etc ...
Read more: Indian pharma cos bracing up to comply with European General Data Protection Regulation

Pharma Reviews: TOP COS IN TROUBLE

That the Indian pharmaceutical industry is going through a difficult period is an undisputed fact, thanks mainly to the unprecedented quality issues being raised by the US FDA. For the last couple of years, the Indian pharmaceutical companies, especially those which have exposure to regulated markets ...
Read more: TOP COS IN TROUBLE

Pharma Reviews: No substitute for quality at low cost for growth-minded Indian pharma cos: David Keeling, McKinsey

David Keeling is senior partner at McKinsey & Company's Chicago office. As group leader, global pharma quality and operations, Keeling leads a team of 300 expert consultants and has the inside track on the global pharmaceutical industry. His India team works closely with top domestic drug makers to ...
Read more: No substitute for quality at low cost for growth-minded Indian pharma cos: David Keeling, McKinsey

Pharma Reviews: IPA releases GDP & PV guidelines to help drug makers meet global quality norms

The Indian Pharmaceutical Alliance (IPA), a representative body of 20 research based pharmaceutical companies in India, has released guidelines on good documentation practice (GDP) and process validation (PV) as part of its ongoing efforts to help the domestic drug makers achieve parity with ...
Read more: IPA releases GDP & PV guidelines to help drug makers meet global quality norms

Pharma Reviews: DoP seeks support from other depts to reduce India's dependence on APIs

In a bid to curb India's dependence on China for active pharmaceutical ingredients (APIs), which are used as raw material ingredients to prepare finished medicines, the Department of Pharmaceuticals (DoP) has requested other government departments to chip in with measures to achieve this.
Read more: DoP seeks support from other depts to reduce India's dependence on APIs

Pharma Reviews: Drug pricing: A regulatory tug of war

The statements were voiced during the closed door session of Union Chemicals and Fertilisers Minister Ananth Kumar with senior executives of pharmaceutical companies in Bengaluru at 'India Pharma 2018' on Feburary 15. During this session, an action taken report, which contained the responses of ...
Read more: Drug pricing: A regulatory tug of war

US FDA News: Bella Diet Capsules by Bella All Natural: Recall - Presence of Sibutramine

Sibutramine and its active metabolites substantially increase blood pressure and/or pulse rate in some patients and may present significant health risks including heart attack, arrhythmia, and stroke.
Read more: Bella Diet Capsules by Bella All Natural: Recall - Presence of Sibutramine

US FDA News: Cardiac Resynchronization Therapy with Defibrillation (CRT-Ds) and Implantable Cardiovert-Defibrillators (ICDs) by Medtronic: Class I Recall- Manufacturing Error Preventing Electrical Shock Delivery

Delay or inability to deliver a shock to a patient in cardiac arrest or pace a patient’s heart whose heartbeat is too slow could result in serious injury and/or death.
Read more: Cardiac Resynchronization Therapy with Defibrillation (CRT-Ds) and Implantable Cardiovert-Defibrillators (ICDs) by Medtronic: Class I Recall- Manufacturing Error Preventing Electrical Shock Delivery

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s ongoing efforts to help improve effectiveness of influenza vaccines

FDA provides update on flu vaccines during this severe flu season
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s ongoing efforts to help improve effectiveness of influenza vaccines

Pharma Reviews: India and Andijan Region of Uzbekistan agree to cooperate for production of pharma & medical ...

India and the Hokimiyat of the Andijan Region of the Republic of Uzbekistan have agreed to cooperate for the production of pharmaceutical, ... and the Ministry of Chemical Industry and Fertilizers of the Republic of India on cooperation in the pharmaceutical industry in the Andijan region of the Republic ...
Read more: India and Andijan Region of Uzbekistan agree to cooperate for production of pharma & medical ...

Pharma Reviews: Is Sun Pharma's Halol site close to a rebound?

About 40% of the US revenues of Sun Pharmaceutical Industries, India's most valuable pharmaceutical company, is linked to its Halol site. For FY17, Sun Pharma had revenues of Rs 30,264 crore, of which Rs 13,300 crore came from the US (including the benefits of exclusivity-period opportunities of the ...
Read more: Is Sun Pharma's Halol site close to a rebound?

Pharma Reviews: African Union to come up with African Medicine Agency to harmonise drug regulation of member ...

This will have a positive impact on Indian pharmaceutical market in medium to long term as Indian market in general has been in a process of steep regulatory tightening in the domestic and surrounding Asian markets. This makes India better equipped as vendors than the mushrooming local companies ...
Read more: African Union to come up with African Medicine Agency to harmonise drug regulation of member ...

Pharma Reviews: Regulators to usher in effective pharmacovigilance with sensitization of MAHs on good PV practices

To help pharma industry develop pharmacovigilance system as per the good pharmacovigilance practices, the Indian Pharmacopoeia Commission (IPC) will soon roll out a series of workshops in Mumbai and Ahmedabad considering the fact that Market Authorisation Holders (MAHs) and regulators ...
Read more: Regulators to usher in effective pharmacovigilance with sensitization of MAHs on good PV practices

Pharma Reviews: NHPS to focus on quality generics, not just branded: Ananth Kumar

Indian pharmaceutical industry earns majority of its revenues by selling branded generic drugs in the country. Generic drugs are cheaper than branded generic drugs. Whenever a drug's patent expires, the company that wants to produce generic version has to get the license for it from the drug regulator.
Read more: NHPS to focus on quality generics, not just branded: Ananth Kumar

Pharma Reviews: Why Indian pharma need to track Amazon's plans in health care

Three recent announcements, two of them linked to Amazon's involvement with health care, have the potential to disrupt the pharmaceutical industry with long term implications for Indian pharmaceutical companies. It is not happening just yet and could arguably take a while but if the recent news reports ...
Read more: Why Indian pharma need to track Amazon's plans in health care

Pharma Reviews: Sun Pharmaceuticals' honcho inks Rs 25000 crore housing deal

Conceptual Advisory Services LLP, a firm in which Sun Pharmaceuticals executive director Sudhir Valia and his wife Raksha are designated partners, ... With the Indian real estate market still stuck in a downturn, several developers have forayed into the budget housing space where the demand remains ...
Read more: Sun Pharmaceuticals' honcho inks Rs 25000 crore housing deal

Pharma Reviews: BioAsia focuses on pharma sector's slow growth rate

HYDERABAD: On the last day of the three-day BioAsia-2018 conference held in Hyderabad, IT and Industries Minister KT Rama Rao, while speaking at a session with Union Minister for industries Suresh Prabhu, raised the issue of the downward spiral of pharmaceutical industry's growth rate in India as ...
Read more: BioAsia focuses on pharma sector's slow growth rate

Pharma Reviews: Ireland woos Hyderabad bio-pharma companies

Hyderabad: Europe is a high value pharmaceuticals market and several Indian companies have either set up their manufacturing facility there or have entered into joint venture to produce and market drugs and vaccines. Realising the importance this market holds for life sciences companies, Ireland, ...
Read more: Ireland woos Hyderabad bio-pharma companies

Pharma Reviews: NPPA will consult pharma industry on pricing: Prabhu

Hyderabad: The National Pharmaceutical Pricing Authority (NPPA), the government body that has the mandate to fix the ceiling on prices of drugs, will take the pharma industry's feedback to ensure that their ... India had specific diseases and the solutions for these should come from India, he said.
Read more: NPPA will consult pharma industry on pricing: Prabhu

Pharma Reviews: Telangana to lobby for pharma industry with Centre

HYDERABAD: Telangana, which contributes to over 35% of India's drug manufacturing, will be approaching the Union ministry of commerce and industries on behalf of the pharma industry to suggest measures to boost the industry whose growth rate for the first time fell below the country's growth rate, ...
Read more: Telangana to lobby for pharma industry with Centre

Pharma Reviews: Indian pharmaceutical industry grown in big way in India as well globally: Suresh Prabhu

... pharmaceuticals conference of the Telangana Government underway at Hyderabad International Convention Centre (HICC), Mr Prabhu said that the demand for healthcare and medication has been increased dramatically as such Indian pharma industry has grown in India but also in globally, he said.
Read more: Indian pharmaceutical industry grown in big way in India as well globally: Suresh Prabhu

Pharma Reviews: Prestigious 15th edition of BioAsia conference concludes

Hyderabad, Feb 24 (UNI) The curtains were rung down on the 15th edition of the BioAsia, the flagship life sciences and pharmaceuticals conference of the ... Union Industry and Commerce Minister Suresh Prabhu, addressing on of the concluding sessions, said that Indian pharmaceutical industry had ...
Read more: Prestigious 15th edition of BioAsia conference concludes

Pharma Jobs: Bio Statistician

Company: Success Booster
Qualification: B.A, B.Sc, M.A, M.Sc
Experience: 3 to 9
location: Bengaluru / Bangalore, Mumbai
Ref: 21917299
Summary: PURPOSE Develop protocols, review case report forms (CRFs), and develop analysis plans. Write specifications for tables and analysis files. Communicate....
Read more: Bio Statistician

Pharma Reviews: Spooling The Tangles

In the last 10-15 years, around $15 billion has been invested in developing drugs for Alzheimer's alone, but every drug has failed. So the outlook here is pretty dim currently with most pharma companies having almost ceased their efforts. Yet, a leading Indian neuroscience researcher says progress ...
Read more: Spooling The Tangles

Pharma Reviews: DCGI plans dedicated cell for start-ups

HYDERABAD:The Drugs Controller General of India (DCGI) plans to set up a dedicated cell for supporting and regulating innovation and start-ups in the pharma sector.There is a need to bridge the gap between regulators and innovators, the newly appointed DCGI, Dr S Eswara Reddy, said at the ...
Read more: DCGI plans dedicated cell for start-ups

US FDA News: Labetalol Hydrochloride Injection by Hospira: Recall - Potential For Cracked Glass At Rim Surface Of Vials

Cracked vials may result in a lack of sterility assurance. Use of or exposure to a non-sterile product may be associated with adverse events such as fever, chills, sepsis or invasive systemic infections in patients.
Read more: Labetalol Hydrochloride Injection by Hospira: Recall - Potential For Cracked Glass At Rim Surface Of Vials

US FDA News: Statement from Stephen Ostroff M.D., Deputy Commissioner for Foods and Veterinary Medicine, on National Toxicology Program draft report on Bisphenol A

FDA provides update on Clarity-BPA
Read more: Statement from Stephen Ostroff M.D., Deputy Commissioner for Foods and Veterinary Medicine, on National Toxicology Program draft report on Bisphenol A

Pharma Reviews: India signs pharma pact with Uzbekistan

India and the Andijan Region of Uzbekistan have inked an agreement for cooperation in the pharmaceutical industry. Both sides will develop cooperation in the implementation of a program for the production of pharmaceutical, bio-pharmaceutical products and medical equipment in the Andijan region ...
Read more: India signs pharma pact with Uzbekistan

Pharma Reviews: India, Uzbek region ink pharma pact

New Delhi: The Andijan Region of Uzbekistan and India have inked an agreement for cooperation in the pharmaceutical industry. ... Both sides have agreed to work together in principle on the issue of creating an Uzbek-Indian free pharmaceutical zone in the Andijan region and start joint development of ...
Read more: India, Uzbek region ink pharma pact

Pharma Reviews: Annaswamy Vaidheesh interview: 'There's general consensus that next price control will happen in ...

Since last round of price control happened in 2016, Vaidheesh, who is also president of the Organisation of Pharmaceutical Producers of India (OPPI), said he expects the government not to make any changes in the price control regime till 2021 as the companies want to do their business planning with ...
Read more: Annaswamy Vaidheesh interview: 'There's general consensus that next price control will happen in ...

US FDA News: Clarithromycin (Biaxin): Drug Safety Communication - Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease

Prescribers advised to consider using other antibiotics in patients with heart disease.
Read more: Clarithromycin (Biaxin): Drug Safety Communication - Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease

Pharma Reviews: UP Investors' Summit 2018: 'Not just investment, we intend to bring our people back...

With people will also come the money they spend outside, he said while batting for more use of technology in the health sector. “Issues such as shortage of doctors and ... “Indian pharma industry is the third largest in the world and it exports 20% of the global generic medicines. India will be a favourite ...
Read more: UP Investors' Summit 2018: 'Not just investment, we intend to bring our people back...

Pharma Reviews: Anti-dumping duty likely on chemical imported from China, Turkey

NEW DELHI: The government is likely to impose anti-dumping duty of up to USD 211 per tonne on a chemical used in textiles and pharma industry, imported ... India has already imposed anti-dumping duty on several products to check cheap imports from countries including China, with which India has a ...
Read more: Anti-dumping duty likely on chemical imported from China, Turkey

Pharma Reviews: Abbott excels on power of brands, outpaces MNC peers on sales growth

Abbott India, the listed subsidiary of the US-based pharma giant, has outpaced its multinational peers to register a 14.6 per cent growth in sales to Rs 25.19 billion in nine months of the current financial. The growth has come at a time when GST implementation affected most Indian pharma companies ...
Read more: Abbott excels on power of brands, outpaces MNC peers on sales growth

Pharma Reviews: US FDA warning letters to Indian pharma decline

Indian Pharmaceutical Alliance Quality Forum has made significant progress in defining best practices. The Quality Forum achieved remarkable success in three focus areas which were outlined by it last year-developing best practice guidelines for Indian pharma companies, expanding reach of QF ...
Read more: US FDA warning letters to Indian pharma decline

Pharma Reviews: Mumbai: Express Healthcare, pharma major talk women issues

Social activists, media professionals, pharmaceutical industry members and doctors participated in a special discussion on Tuesday to deliberate on ... institutes and workplaces for women's health, and regular check-ups, and focusing on scientific approach could improve women health in India.
Read more: Mumbai: Express Healthcare, pharma major talk women issues

Product Recall Alerts: Urgent warning as thousands of asthma inhalers recalled due to safety fears

The Medicines and Healthcare products Regulatory Agency (MHRA) issued a patient level drug alert recalling two specific affected lots manufactured by Glaxo Wellcome UK Limited. Experts warned that due to a manufacturing issue a small number of the devices are not delivering the full number of ...
Read more: Urgent warning as thousands of asthma inhalers recalled due to safety fears

Pharma Reviews: BioAsia to begin in Hyderabad from February 22

Hyderabad: BioAsia, the annual flagship event of the Government of Telangana, will deliberate on a range of issues plaguing the Indian Pharma sector, including the revenue loss impacting Indian companies and decreasing market capitalisation due to increasing regulatory concerns from the United ...
Read more: BioAsia to begin in Hyderabad from February 22

US FDA News: FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid

FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid
Read more: FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid

Pharma Reviews: Indian shares rise after 3 sessions of falls; IT stocks lead

Indian shares rise after 3 sessions of falls; IT stocks lead ... Feb 21 (Reuters) - Indian shares edged up on Wednesday after three straight sessions of falls, with IT stocks extending gains after an industry lobby group on Tuesday ... Pharma stocks also fell with the Nifty Pharma index down nearly 3 percent.
Read more: Indian shares rise after 3 sessions of falls; IT stocks lead

Pharma Reviews: Nifty, Sensex rise after three sessions of falls; IT stocks lead

MUMBAI: Indian shares edged up on Wednesday after three straight sessions of falls, with IT stocks extending gains after an industry lobby group on Tuesday ... Pharma stocks also fell with the Nifty Pharma index down nearly 3 percent. Sun Pharmaceutical Industries dropped as much as 8.6 percent.
Read more: Nifty, Sensex rise after three sessions of falls; IT stocks lead

Pharma Reviews: Meeting the soaring demands of Pharma & Biotech industry through electronic commerce

The Indian Pharmaceutical and Biotechnology sector is expected to grow enormously in the next few years owing to the new funding programs implemented by the Govt. of India to encourage research & manufacturing in the country. With this, one may anticipate increased demands for supplies to run ...
Read more: Meeting the soaring demands of Pharma & Biotech industry through electronic commerce

Pharma Reviews: Lessons from Ranbaxy: Suffocating Silence Prevented Us From Questioning the Rot in the System

And what of the well-meaning arm-chair public health experts who made absurd assertions vouching for the company's products on various television debates and in newspaper reports? What basis did they have in providing cover to an outright fraud by India's largest pharmaceutical company at the ...
Read more: Lessons from Ranbaxy: Suffocating Silence Prevented Us From Questioning the Rot in the System

Pharma Reviews: If Sun Pharma inspections come through, 2018 could be a turning point for Indian pharma: Amit ...

For the oral doses form, the pain point is behind us now. Now with the news that Warren Buffett is coming to invest in Teva, the biggest trigger that Indian pharma will get and that is going to shape up the Indian pharma industry would be the outcome of the current inspection that is going now in Sun ...
Read more: If Sun Pharma inspections come through, 2018 could be a turning point for Indian pharma: Amit ...

Pharma Reviews: Maha FDA urges CDSCO to consider industry plea towards easing out repeated joint inspections ...

Till about a decade ago, China was trying to catch up with India in APIs. Today, with their Government's unstinted support, they have moved far ahead and Indian pharmaceutical industry is trying to catch up with them. There is an urgent need for the government to support the industry with a conducive ...
Read more: Maha FDA urges CDSCO to consider industry plea towards easing out repeated joint inspections ...

Pharma Reviews: Import of growth drug oxytocin may be banned to curb misuse

Some of them are Hemmo Pharmaceutical Pvt. Ltd, Pfizer Ltd, Cadila healthcare Ltd and Troikaa Pharmaceuticals Ltd. “It's illegally imported into the country through the Afghanistan and Bangladesh borders and if the import is banned, local active ingredient manufacturers stand to benefit. In India, most ...
Read more: Import of growth drug oxytocin may be banned to curb misuse

Pharma Reviews: New Delhi, Feb 17 (PTI) Pharma and medical devices makers have urged the government to take ...

Chief executives of pharma and medical devices firms, who met Union Minister of Chemicals and Fertilisers Ananth Kumar during the third edition of the India Pharma and Medical Device 2018 conclave, also said they are eagerly awaiting the swift implementation of the Ayushman Bharat insurance ...
Read more: New Delhi, Feb 17 (PTI) Pharma and medical devices makers have urged the government to take ...

Pharma Reviews: Medical devices sector needs compendium on similar lines of Pharmacopeia to bring in uniformity ...

Indian medical device sector requires a compendium on similar lines that of Pharmacopeia that will have monographs for all medical devices with ... Make in India initiative will be a quality initiative, said Kohli on the sidelines of the 3rd edition of the India Pharma 2018 and India Medical Devices 2018 in ...
Read more: Medical devices sector needs compendium on similar lines of Pharmacopeia to bring in uniformity ...

Pharma Reviews: Price control not the best way to achieve affordability: NPPA Chairman Bhupendra Singh

While the National Pharmaceutical Pricing Authority (NPPA) revised the ceiling price on coronary stents on Monday, its Chairman Bhupendra Singh stated on ... For me, in my scheme of things, price control is the last (option),” Singh stated at the 'India Pharma 2018' exhibition in Bengaluru on Friday.
Read more: Price control not the best way to achieve affordability: NPPA Chairman Bhupendra Singh

US FDA News: FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing

FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing
Read more: FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing

Pharma Reviews: Industry leaders from pharma and medical devices sectors raise key demands with the Government

A delegation of key industry leaders from the pharma and medical devices sectors highlighted their pressing demands and concerns to the Union minister of Chemicals & Fertilizers Mr. Ananth Kumar at the third edition of India Pharma and Medical Device 2018 that is being held in Bengaluru from Feb ...
Read more: Industry leaders from pharma and medical devices sectors raise key demands with the Government

Pharma Reviews: Separate medical devices from Drugs : Industry leaders

Bengaluru, Feb 16 (UNI) A delegation of key industry leaders from the pharma and medical devices sectors highlighted their pressing demands and ... They met Union minister of Chemicals and Fertilizers Ananth Kumar at the third edition of India Pharma and Medical Device 2018 here on Friday and ...
Read more: Separate medical devices from Drugs : Industry leaders

Pharma Reviews: GE Healthcare bags The Indian Medical Device Company of the Year award

GE Healthcare was announced as the Indian Medical Device Company of the Year 2018 at India's biggest Global Conference on Pharma Industry and Medical Devices. The 'India Pharma & India Medical Device 2018' conference, with the theme - 'Affordable and Quality Healthcare', is the 3rd ...
Read more: GE Healthcare bags The Indian Medical Device Company of the Year award

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on the efficacy of the 2017-2018 influenza vaccine

FDA provides update on flu vaccines during this severe flu season
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on the efficacy of the 2017-2018 influenza vaccine

Pharma Reviews: 'Namocare' to boost pharma sector: Ananth Kumar

After inaugurating the third edition of India Pharma 2018 and India Medical Device 2018, a three-day event that brings together stakeholders in pharma and medical device sectors across the country here on Thursday, the Minister said, "Ayushman Bharat will fundamentally change Indian healthcare.
Read more: 'Namocare' to boost pharma sector: Ananth Kumar

Pharma Reviews: National Health Protection Scheme: 'Universal healthcare has to be co-opted in new pharma policy'

At the inaugural ceremony on Thursday morning, S Sridhar, Managing Director, Pfizer Limited – who is also the Co-Chair of the FICCI Pharmaceutical Committee – stated that Indian pharmaceutical industry remains in a constant state of uncertainty due to frequent policy changes. Sridhar stated: “In last ...
Read more: National Health Protection Scheme: 'Universal healthcare has to be co-opted in new pharma policy'

Pharma Reviews: New pharmaceuticals policy on the cards: Minister

While inaugurating the third edition of India Pharma 2018 and India Medical Device 2018, Ananthkumar said, “Namo-Care cannot be effectively implemented in the currently fragmented ecosystem of the pharma industry. The Government accordingly intends to come up with a New Pharma Policy which ...
Read more: New pharmaceuticals policy on the cards: Minister

Pharma Reviews: India's biggest Annual Conference on Pharma Industry and Medical Devices – India Pharma 2018 ...

Bengaluru: “Ayushman Bharat health insurance scheme announced by the Government, popularly called as 'Namo-Care', has the potential to turn India into the largest pharma manufacturer of the world in about three years”, Union Minister of Chemicals & Fertilizers and Parliamentary Affairs, Shri ...
Read more: India's biggest Annual Conference on Pharma Industry and Medical Devices – India Pharma 2018 ...

Pharma Reviews: 'Namocare' to make India largest drug maker: Union Minister

"The pharma and medical devices industry has to take up the Namocare challenge in coordination with the 'Make in India' initiative to ensure health security for all," he said, adding he had given the stakeholders a 3A formula - 'availability, authenticity and affordability without compromising on quality'.
Read more: 'Namocare' to make India largest drug maker: Union Minister

US FDA News: FDA expands treatment window for use of clot retrieval devices in certain stroke patients

FDA expands treatment window for use of clot retrieval devices in certain stroke patient
Read more: FDA expands treatment window for use of clot retrieval devices in certain stroke patients

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on advancing the development of novel treatments for neurological conditions; part of broader effort on modernizing FDA’s new drug review programs

FDA’s 5 guidance documents provide details for drug development for neurological conditions such as ALS and Alzheimer’s disease
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on advancing the development of novel treatments for neurological conditions; part of broader effort on modernizing FDA’s new drug review programs

Pharma Reviews: Pharma & Medical devices industry should gearup for 'Ayushman Bharat' : Anant Kumar

Bengaluru, Feb 15 (UNI) Union Minister for Chemicals and Fertilizers Anant Kumar on Thursday exhorted the Indian Pharma and Medical Devices Industry to brace up for meeting the demands of the most ambitious health insurance scheme 'Ayushman Bharat' which will be rolled out by the government ...
Read more: Pharma & Medical devices industry should gearup for 'Ayushman Bharat' : Anant Kumar

Pharma Reviews: Transasia wins India Medical Devices Export Company of the Year

Mr. Suresh Vazirani, Chairman & Managing Director, Transasia Bio-Medicals Ltd. received the award through the hands of Shri Ananth Kumar, Hon'ble Minister (Chemicals & Fertilizers), Government of India, at the 3^rd International Exhibition & Conference on Pharmaceutical & Medical Devices Industry ...
Read more: Transasia wins India Medical Devices Export Company of the Year

Pharma Reviews: Bengaluru hosts the biggest annual conference on Pharma industry & Medical Devices

Namo-Care to turn India into largest pharma manufacturer in the world in three years: Union Minister Mr. Ananth Kumar ... The minister also said that the country needed a new ministry of Pharma and Medical Devices as various parts of the industry currently were under the ambit of different ministries, ...
Read more: Bengaluru hosts the biggest annual conference on Pharma industry & Medical Devices

Pharma Reviews: Dr. Srinivasa Reddy bags prestigious Sun Pharma Research Award

He received the award by Mr. Dilip Shanghvi, Managing Director, Sun Pharmaceutical Industries Ltd. and Prof. Vishwajit Nimgaonkar, University of Pittsburgh, USA at a function held in India Habitat Centre in New Delhi on 12th February. Dr. Reddy is working in the area of total synthesis of biologically ...
Read more: Dr. Srinivasa Reddy bags prestigious Sun Pharma Research Award

Pharma Reviews: Warren Buffet's Teva investment - a sentimental booster or revival in pharma sector expected?

The effect is clearly visible in the share prices of the pharma companies. The market cap of three large pharma companies in India i.e. Sun Pharma, Lupin and Dr. Reddy's have halved over the past two years. And then, there are also more no casualties beyond these three large companies.
Read more: Warren Buffet's Teva investment - a sentimental booster or revival in pharma sector expected?

Pharma Reviews: Fuelling pharma industry's growth: How overall reliability will improve

India is ranked third regarding global pharma volume, leading in all the four key segments—Active Pharmaceutical Ingredient, Formulations, Biosimilars and Contract Research Services. It supplies 20% of global exports in generics, to over 200 countries, and the projected CAGR over 2015-20 is 12.89% ...
Read more: Fuelling pharma industry's growth: How overall reliability will improve

US FDA News: FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint

FDA approves Erleada (apalutamide), first treatment for non-metastatic, castration-resistant prostate cancer
Read more: FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint

US FDA News: FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults

FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults; new quick testing option to help reduce need for CT scans, radiation exposure for patients
Read more: FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults

Pharma Reviews: Calcutta HC strikes down Centre's decision to sell stake in Bengal Chemicals

The Centre had argued that the five state-owned drug makers had combined revenue of Rs500-550 crore in the past three years, accounting for less than 5% of the sales of Indian pharmaceutical industry. These enterprises were no longer of “strategic value” because they did not produce anything that ...
Read more: Calcutta HC strikes down Centre's decision to sell stake in Bengal Chemicals

Pharma Reviews: Paytm Takes Cues From Alibaba in Indian New Retail Experiment

India's largest drugmaker Sun Pharmaceutical Industries Ltd.'s profit declined in the quarter ended December due to a one-time tax payout and weak performance of its Israeli subsidiary. Net profit fell 75.2 percent year-on-year to Rs 365.39 crore in the third quarter, the company said in a stock exchange ...
Read more: Paytm Takes Cues From Alibaba in Indian New Retail Experiment

Pharma Reviews: No shortage of stents after price caps as Indian, Chinese firms fill void

Belying the fear that there would be a shortage of coronary stents in the market after India imposed a price ceiling last year, which it further lowered this week, India faces no such shortage, according to data from the National Pharmaceutical Pricing Authority (NPPA). The data reflects that while there was ...
Read more: No shortage of stents after price caps as Indian, Chinese firms fill void

Pharma Reviews: Why Pradip P Shah of IndAsia is sceptical about this sector

IT companies have adapted to the requirements of their customers in terms of providing solutions rather than just providing engineers to solve their application development services issues. Similarly, in the pharma industry the United States, which is one of the buyers will have to come back to India.
Read more: Why Pradip P Shah of IndAsia is sceptical about this sector

Pharma Reviews: IPA convention stresses need for joint deliberations by govt and industry to make India self ...

The recently concluded 7th national convention of the Indian Pharmaceutical Association (IPA) stressed the need for joint deliberations by government and the industry on how India can become self-reliant in the production of active pharmaceutical ingredients (APIs), intermediaries and excipients for ...
Read more: IPA convention stresses need for joint deliberations by govt and industry to make India self ...

Pharma Reviews: Govt may cap trade margins to control drug prices

In November, while hearing a public interest litigation filed by the All India Drug Action Network (AIDAN), a network of pharmaceutical non-governmental organizations, the Supreme Court had termed the existing procedure of controlling prices of medicines on the basis of market-based competition ...
Read more: Govt may cap trade margins to control drug prices

US FDA News: Acyclovir 400mg Tablets by Apace Packaging: Recall - Product Mix-up

Missing a dose of Acyclovir Tablets could cause a reactivation of a virus being treated.
Read more: Acyclovir 400mg Tablets by Apace Packaging: Recall - Product Mix-up

US FDA News: FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients

FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients
Read more: FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote innovation and broaden patient access through competition

Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote innovation and broaden patient access through competition
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote innovation and broaden patient access through competition

Pharma Reviews: Global conference on pharma sector to kick off in Feb 15

A three-day Global Conference on Pharma Industry and Medical Devices will kick off in Bengalure from February 15, said the government. The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, along with Federation of Indian Chambers of Commerce & Industry (FICCI), ...
Read more: Global conference on pharma sector to kick off in Feb 15

Pharma Reviews: India's biggest global pharma conference in Bengaluru

New Delhi, Feb 13 (UNI) An international exhibition and conference on Pharmaceutical & Medical Device sector 'India Pharma & India Medical ... the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilisers, along with Federation of Indian Chambers of Commerce & Industry (FICCI).
Read more: India's biggest global pharma conference in Bengaluru

Pharma Reviews: Commerce Secretary level meeting between India and Bangladesh held on 7th -8th February 2018 ...

The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, along with Federation of Indian Chambers of Commerce & Industry (FICCI), is organizing India Pharma & India Medical Device 2018, with the theme - Affordable and Quality Healthcare, the 3^rd International exhibition and ...
Read more: Commerce Secretary level meeting between India and Bangladesh held on 7th -8th February 2018 ...

Pharma Reviews: Industry stalwarts pledge to take India beyond all frontiers in volume of drug production and in ...

The committed personalities of the Indian pharmaceutical sector assembled on the platform of the 7th National Convention of the Indian Pharmaceutical Association (IPA) in Chennai last week. The Convention identified five focus areas as strategic pillars to adapt Indian pharmaceutical sector for a world ...
Read more: Industry stalwarts pledge to take India beyond all frontiers in volume of drug production and in ...

Pharma Reviews: 'India Pharma & India Medical Device 2018' to be held in Bengaluru from Feb 15-17

The third international conference and exhibition on pharmaceuticals industry and medical devices, 'India Pharma & India Medical Device 2018', will be held at Bengaluru from February 15-17, 2018, by the Federation of Indian Chambers of Commerce and Industry (FICCI) in collaboration with the ...
Read more: 'India Pharma & India Medical Device 2018' to be held in Bengaluru from Feb 15-17

Pharma Reviews: The inside story of how Ajay Piramal's pharma empire received a boost after the Abbott sale

"Integrating American and Indian cultures is probably one of the most engaging parts of my job," says Michael Jordan, head of HR, Piramal Pharma Solutions. ... Group chairman Ajay Piramal offers a sneak peek into his mind when he says the industry has undergone a sea change in these eight years.
Read more: The inside story of how Ajay Piramal's pharma empire received a boost after the Abbott sale

Pharma Reviews: BioAsia to focus on regulatory challenges in pharma

According to a study conducted by BioAsia along with knowledge partner Deloitte, the financial year 2016-2017 has been among the toughest years for the Indian Pharma companies due to frequent foreign regulatory interventions and major domestic structural policy initiatives. It has been noted that ...
Read more: BioAsia to focus on regulatory challenges in pharma

Pharma Reviews: US Drug Regulator Starts Reinspecting Sun Pharma's Halol Facility

The U.S. drug regulator started reinspecting Sun Pharmaceutical Industries Ltd.'s facility in Halol, Gujarat, one of its biggest units that's barred from new drug filings in the ... The second bidder for Essar Steel is ArcelorMittal, which is bidding through its subsidiary ArcelorMittal India Pvt. Ltd (AMIPL).
Read more: US Drug Regulator Starts Reinspecting Sun Pharma's Halol Facility

Pharma Reviews: Bengaluru to witness India's biggest global conference on pharma industry and medical devices

The third international conference and exhibition on pharmaceuticals industry and medical devices, India Pharma & India Medical Device 2018, will be held at Bengaluru from February 15-17, 2018, by the Federation of Indian Chambers of Commerce and Industry (FICCI) in collaboration with the Dept. of ...
Read more: Bengaluru to witness India's biggest global conference on pharma industry and medical devices

Pharma Reviews: How prepared are they?

However, in the recent period, FMCG and pharma sectors lost their sheen due to structural headwinds. The FMCG sector registered a dismal growth over the last two years due to demand slowdown, demonetisation and GST. The Indian pharmaceutical industry has been also going through a tough ...
Read more: How prepared are they?

Pharma Reviews: / USTR urged to remove India from Priority Watch List

"It is now clear that substantial and consistent progress has been made by India and overall, Indian laws relating to patents and their application do not deny adequate and effective protection of IPR, nor do they deny fair and equitable market access to the US pharmaceutical industry which relies on ...
Read more: / USTR urged to remove India from Priority Watch List

US FDA News: HeartStart MRx Defibrillator by Philips Electronics: Class I Recall - Defects in Gas Discharge Tubes May Cause Device Failure

Continued use of the device in AED mode after failure may lead to serious patient injury or death.
Read more: HeartStart MRx Defibrillator by Philips Electronics: Class I Recall - Defects in Gas Discharge Tubes May Cause Device Failure

Pharma Reviews: Ireland waiting to woo Indian pharma firms

The Indian industry has seen challenges such as profit erosion, South East Asian competitors, Brexit and lack of new opportunities in tradition chemistry-based products, she said. BioAsia would help Ireland showcase its achievements in bio-pharmaceuticals and life sciences sectors, said Industries ...
Read more: Ireland waiting to woo Indian pharma firms

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on groundbreaking approval and interagency approach to bring stable supply of critical medical imaging isotope to the U.S.

FDA announces on groundbreaking approval and interagency approach to bring stable supply of critical medical imaging isotope to the U.S.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on groundbreaking approval and interagency approach to bring stable supply of critical medical imaging isotope to the U.S.

US FDA News: FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging

FDA and NRC today took important steps to ensure a stable and secure supply of a critical radioactive imaging product used to detect potentially life-threatening diseases
Read more: FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging

Pharma Reviews: BioAsia 2018: Ireland encourages Indian pharma firms

Ireland is looking forward to BioAsia 2018, the next in the series of the premier event for life sciences, pharmaceuticals and healthcare sector, to encourage Indian pharma companies. BioAsia will be held in Hyderabad on 22^nd February to provide a platform to companies, research institutes, investors ...
Read more: BioAsia 2018: Ireland encourages Indian pharma firms

Pharma Reviews: IRB Infrastructure Developers Ltd

The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, ...
Read more: IRB Infrastructure Developers Ltd

Pharma Reviews: Results to watch out - Eicher Motors, Aurobindo Pharma, Cipla

Cipla is third largest Indian pharma company and has presence in countries like the US, South Africa, etc. Company is ranked ninth largest company by number of prescription in the US market. It derives 38% revenue from India, 22% from Emerging markets, 18% from US, 12% from South Africa and rest ...
Read more: Results to watch out - Eicher Motors, Aurobindo Pharma, Cipla

Pharma Reviews: Pharma industry links to rising antimicrobial resistance levels

According to latest reports, decades of campaigning by local and international NGOs alongside successful legal challenges in Indian courts has not led to curbing of emissions. Pharmaceutical pollution is still rife in Hyderabad, affecting ecosystems and human lives, as companies continue to discharge ...
Read more: Pharma industry links to rising antimicrobial resistance levels

Pharma Reviews: Spot Market Update: Turmeric Plummets On Limited Export Buying

By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in ...
Read more: Spot Market Update: Turmeric Plummets On Limited Export Buying

Pharma Reviews: Ireland waiting to woo Indian pharma firms

Ireland is looking forward to BioAsia 2018, the next in the series of the premier event for life sciences, pharmaceuticals and healthcare sector, to woo Indian pharma companies. “We are witnessing an increasing number of Indian companies ,using Ireland as the gateway to Europe,” director for IDA ...
Read more: Ireland waiting to woo Indian pharma firms

US FDA News: Pentax Medical Duodenoscope Model ED-3490TK: FDA Safety Communication - Updated Design and Labeling Cleared

Design changes are intended to reduce the potential for leakage of patient fluids into the closed elevator channel and under the distal cap.
Read more: Pentax Medical Duodenoscope Model ED-3490TK: FDA Safety Communication - Updated Design and Labeling Cleared

Pharma Reviews: Pharma industry links to rising antimicrobial resistance levels

New Delhi [India], Feb.7 : Turns out, India's pharmaceutical industry is contributing to rising antimicrobial resistance (AMR) levels due to their polluters - air, soil and water. It is found that exposure to these polluters are aiding the development of AMR in population at large. India's pharmaceutical industry ...
Read more: Pharma industry links to rising antimicrobial resistance levels

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse

FDA statement on scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse

Pharma Reviews: Pharma: Shrinking Fortunes

Sun Pharma is not the only one which is facing increase in competition in the generics market along with greater pricing scrutiny in the US. Glenmark Pharmaceuticals also reported a 4.2 per cent year-on-year drop in September quarter consolidated net profit to Rs 214.12 crore on weak US sales, the ...
Read more: Pharma: Shrinking Fortunes

Pharma Reviews: Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs: sources

By Pamela Barbaglia, Arno Schuetze and Dasha Afanasieva. LONDON/FRANKFURT - Brazilian drugs firm EMS and Indian rival Torrent Pharma have emerged as the only industry bidders for Sanofi's generic drugs unit, battling a series of buyout funds for an asset worth as much as $2.4 billion, sources ...
Read more: Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs: sources

Pharma Reviews: Indian drug firms' growth slowed in 2017 on slow approvals, MNCs' caught up

Home-grown pharmaceutical companies in 2017 saw some erosion in their edge over multinational peers in the domestic drug market. Tempering the past year's trend of a significant lead, Indian drug firms grew at almost the same rate as their MNC counterparts. While Indian pharma players clocked a ...
Read more: Indian drug firms' growth slowed in 2017 on slow approvals, MNCs' caught up

US FDA News: Extracorporeal Photopheresis (ECP) Treatment : Letter to Health Care Providers - Death and Pulmonary Embolism

FDA has received seven reports of patients experiencing PE during, or soon after, a treatment.
Read more: Extracorporeal Photopheresis (ECP) Treatment : Letter to Health Care Providers - Death and Pulmonary Embolism

Pharma Reviews: Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs: sources

For India's Torrent Pharma, which has a market value of $3.4 billion, the deal would grant access to various European markets. Brazil's EMS has already built a small presence in Central and Eastern Europe with the 2017 purchase of Serbian laboratory Galenika. Sanofi first hinted at a possible disposal ...
Read more: Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs: sources

Pharma Reviews: Global Investment Summit: Assam Ready to 'tweak' Investment Policy for Pharma Industry, Says ...

A Memorandum of Understanding was signed here between Indian Institute of Technology-Guwahati and Kalam Institute of Health Technology to source innovation from the Assam-based centre and auction them to the industry. The Government wants to transform the state and create jobs for the youths.
Read more: Global Investment Summit: Assam Ready to 'tweak' Investment Policy for Pharma Industry, Says ...

Pharma Reviews: Assam minister woos pharma industry

Guwahati: The Assam government said on Sunday that it was ready to tweak its investment policies to attract the pharmaceutical sector for setting up units ... An MoU was signed between the Indian Institute of Technology, Guwahati and the Kalam Institute of Health Technology to source innovation from ...
Read more: Assam minister woos pharma industry

Pharma Jobs: Urgent opening for Respiratory therapists, clinical perfusionists and cardiopulmonary tech in CANADA

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate
Experience: 3 to 8
location: Canada
Ref: 21831918
Summary: Respiratory therapists assist physicians in the diagnosis, treatment and care of patients with respiratory and cardiopulmonary disorders. Clinical perfusionists provide technical....
Read more: Urgent opening for Respiratory therapists, clinical perfusionists and cardiopulmonary tech in CANADA

Pharma Reviews: Inventive IT startup races ahead of the pack

It is being used in a number of pharmaceutical production facilities, blood banks and hospitals from where the feedback is upbeat. It promises to be the coolest technology product for the Indian pharmaceutical industry in 2018 and place its creator as one of the most promising of startups in India.
Read more: Inventive IT startup races ahead of the pack

Pharma Reviews: Assam for tweaking investment policy for pharma industry

Guwahati, Feb 4 (PTI) Assam government today said it is ready to tweak its investment policies to attract the pharmaceutical sector for setting up units in the ... On this occasion, a Memorandum of Understanding was signed between Indian Institute of Technology-Guwahati and Kalam Institute of Health ...
Read more: Assam for tweaking investment policy for pharma industry

Pharma Reviews: Assam for tweaking investment policy for pharma industry

Guwahati: Assam government on Sunday said it is ready to tweak its investment policies to attract the pharmaceutical sector for setting up units in the state. ... On this occasion, a memorandum of understanding was signed between Indian Institute of Technology-Guwahati and Kalam Institute of Health ...
Read more: Assam for tweaking investment policy for pharma industry

Pharma Jobs: MSC Bio Science (Analist Role) Fresher & 1 Year Experience) Excellent Package

Company: Spaceinfo Soft Tech Private Limited
Qualification: M.Sc
Experience: 0 to 2
location: Bengaluru / Bangalore, Hyderabad / Secunderabad
Ref: 21831512
Summary: MSC Bio Science (Analist Role) Fresher & 1 Year Experience) Excellent Package

Read more: MSC Bio Science (Analist Role) Fresher & 1 Year Experience) Excellent Package

US FDA News: Statement from Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health on the recent National Toxicology Program draft report on radiofrequency energy exposure

One part of the Food and Drug Administration’s mission is to ensure the safety of electronic products that emit radiation, like televisions and cell phones. These types of products are part of Americans’ daily life and we take our duty to protect consumers with the utmost gravity. With cell phones, we have relied extensively on a myriad scientific evidence developed over many years to help inform our regulatory thinking. Although the Federal Communications Commission (FCC) sets the standard for radiofrequency energy exposure limits from cell phones, the FCC relies on the FDA and other health agencies for scientific expertise and input regarding those standards.
Read more: Statement from Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health on the recent National Toxicology Program draft report on radiofrequency energy exposure

US FDA News: Gericare Eye Wash by Kareway Products: Recall - Potential Product Contamination

Probability of a potentially sight threatening eye infection or impairment.
Read more: Gericare Eye Wash by Kareway Products: Recall - Potential Product Contamination

Pharma Reviews: India needs to re-look at services issue in RCEP: Girija Pande

Indian industry must be more positive and 'Act East', as the PM said, and take a leap confidently. They are quite effective ... Indian industry is not scared of Asean (Association of Southeast Asian Nations), but the China factor. They are worried that ... etc., ditto Indian pharma or, now, media. Japanese and ...
Read more: India needs to re-look at services issue in RCEP: Girija Pande

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to mitigate impact of saline shortages during this flu season

FDA provides update on ongoing efforts to mitigate impact of saline shortages and monitor other critical products during flu season
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to mitigate impact of saline shortages during this flu season

Pharma Reviews: Top 50 stocks that may get a Budget lift-off

According to UBM India, with the government's vision of making India as one of the top 3 countries in the pharma industry globally, the government should allocate more funds for R&D and innovation and should increase it to 2 per cent-3 per cent of GDP from 0.69 per cent GDP at present in their budget ...
Read more: Top 50 stocks that may get a Budget lift-off

US FDA News: Ocaliva (obeticholic acid): Drug Safety Communication - Boxed Warning Added To Highlight Correct Dosing

FDA is clarifying the current recommendations for screening, dosing, monitoring, and managing PBC patients with moderate to severe liver disease taking Ocaliva.
Read more: Ocaliva (obeticholic acid): Drug Safety Communication - Boxed Warning Added To Highlight Correct Dosing

Pharma Reviews: Budget 2018: Govt's healthcare proposals to create more demand for medicines

"Unless, the current aberrations in implementation of the pricing policy is corrected, the country may witness imbalance between the growing demand and supply of medicines, which may remain stagnant," says D.G. Shah, Secretary General of the Indian Pharmaceutical Alliance that has some of the ...
Read more: Budget 2018: Govt's healthcare proposals to create more demand for medicines

Pharma Reviews: Industry experts react to Budget 2018: cheers for agri push, mixed response to corporate taxation

Share prices of most of the pharma companies like GSK, Glenmark, Divis Laboratories went up when this announcement was made by the Finance ... India still looks at tax benefits for insurance premium payments and this would, therefore, be an effective stimulus towards increase of penetration of ...
Read more: Industry experts react to Budget 2018: cheers for agri push, mixed response to corporate taxation